scholarly article | Q13442814 |
P356 | DOI | 10.1007/BF01536055 |
P698 | PubMed publication ID | 2914542 |
P2093 | author name string | I J Sarfeh | |
H Soliman | |||
A Tarnawski | |||
H X Bui | |||
K Waxman | |||
M Coccia | |||
E B Rypins | |||
P2860 | cites work | Gastric lesions in portal hypertension: inflammatory gastritis or congestive gastropathy? | Q34527552 |
The gastric mucosa in portal hypertension: effects of topical bile acid. | Q41584647 | ||
Hyperdynamic circulation in portal-hypertensive rat model: a primary factor for maintenance of chronic portal hypertension | Q41605578 | ||
Emergency PaO2 estimates in one minute with a transcutaneous oxygen sensor | Q42091992 | ||
Regeneration of gastric mucosa after aspirin-induced injury in the rat. | Q44427882 | ||
Effects of portacaval shunt and hepatic artery ligation on liver surface oxygen tension and effective hepatic blood flow | Q44802372 | ||
Protective effect of pentoxifylline on gastric mucosa | Q46294794 | ||
Bile acid-induced gastric mucosal injury: significance of portal hypertension and mucosal capillary permeability. | Q50922891 | ||
Morphology of gastric microcirculation in cirrhosis. | Q54488343 | ||
Portal hypertension and gastric mucosal injury in rats. Effects of alcohol | Q67275730 | ||
Changes of gastric blood flow in experimentally induced cirrhosis of the liver | Q67412124 | ||
Method for intraoperative assessment of organ perfusion and viability using a miniature oxygen sensor | Q70607722 | ||
Histologic and microcirculatory changes in alcohol-induced gastric lesions in the rat: effect of prostaglandin cytoprotection | Q72745517 | ||
P433 | issue | 2 | |
P304 | page(s) | 225-228 | |
P577 | publication date | 1989-02-01 | |
P1433 | published in | Digestive Diseases and Sciences | Q15716711 |
P1476 | title | Impaired oxygenation of gastric mucosa in portal hypertension. The basis for increased susceptibility to injury | |
P478 | volume | 34 |
Q38519263 | Abnormal PTEN expression in portal hypertensive gastric mucosa: A key to impaired PI 3‐kinase/Akt activation and delayed injury healing? |
Q28581343 | Activation of eNOS in rat portal hypertensive gastric mucosa is mediated by TNF-alpha via the PI 3-kinase-Akt signaling pathway |
Q54269127 | Adenosine receptor blockade reduces splanchnic hyperemia in cirrhotic rats. |
Q74576145 | Alterations in colonic mucosal vessels in patients with cirrhosis and noncirrhotic portal hypertension |
Q45190970 | An endoscopic study of upper-GI mucosal changes in patients with congestive heart failure |
Q72026726 | Associations of peptic ulcer and gastric cancer with other diseases in US veterans |
Q36996251 | Avoiding pitfalls: what an endoscopist should know in liver transplantation--part 1. |
Q44116705 | Cirrhotic patients at increased risk of peptic ulcer bleeding: a nationwide population-based cohort study |
Q43586180 | Colonic mucosal changes in patients with liver cirrhosis |
Q34394489 | Congestive gastropathy and Helicobacter pylori: an endoscopic and morphometric study |
Q34376668 | Congestive jejunopathy in portal hypertension |
Q50526731 | Cytoprotective activity in the gastric mucosa of rats exposed to carbon tetrachloride-induced liver injury. |
Q72566379 | Endoscopic ultrasonographic evaluation of the rectum in cirrhotic portal hypertension |
Q47781941 | Factors predisposing to peptic ulcer disease in asymptomatic cirrhotic patients. |
Q72016060 | Gastric Mucosal hemodynamics in portal-hypertensive gastropathy: The debate goes on |
Q43585854 | Gastric epithelial cell proliferation in patients with liver cirrhosis |
Q28175110 | Gastric mucosal resistance to acute injury in experimental portal hypertension |
Q71506730 | Gastric mucus generation in cirrhotic patients with portal hypertension. Effects of tetraprenylacetone |
Q40811158 | Gastric secretion and peptic ulceration in cirrhosis |
Q43820278 | Gastromucosal lesions in rabbits with chronic schistosomiasis |
Q35142223 | Helicobacter pylori infection in patients with liver cirrhosis: facts and fictions |
Q53830383 | Immunohistochemical localization of vascular endothelial growth factor in the rat portal hypertensive gastropathy. |
Q77947796 | Impaired adaptive cytoprotection to ethanol-induced damage in gastric mucosa of portal hypertensive rats |
Q50529723 | Increased gastric bicarbonate secretion in portal hypertensive anesthetized rats: role of prostaglandins and nitric oxide. |
Q44125723 | Increased oxidative stress may lead to impaired adaptive cytoprotection in the gastric mucosa of portal hypertensive rat. |
Q37777475 | Management of Gastropathy and Gastric Vascular Ectasia in Portal Hypertension |
Q43669345 | Modulation of acid secretion in common bile duct ligation-related gastropathy in Wistar rats |
Q73187425 | New insights into impairment of mucosal defense in portal hypertensive gastric mucosa |
Q73880770 | Overexpression of endothelin-1 mRNA and protein in portal hypertensive gastric mucosa of rats: a key to increased susceptibility to damage? |
Q37384685 | Pathogenesis of portal hypertensive gastropathy: translating basic research into clinical practice |
Q42214257 | Peptic ulcer disease in liver cirrhosis and chronic hepatitis: impact of portal hypertension. |
Q35840379 | Portal hypertensive gastropathy and gastric antral vascular ectasia |
Q80152566 | Portal-hypertensive-gastropathy-like changes in a patient with secondary polycythemia: reversal of endoscopic and histopathologic changes with phlebotomy |
Q51027717 | Prevalence of gastric ulcer in cirrhotic patients and its relation to portal hypertension. |
Q46372766 | Significance of ERK nitration in portal hypertensive gastropathy and its therapeutic implications |
Q36865839 | Small bowel abnormalities in patients with compensated liver cirrhosis. |
Q43212541 | Taurocholate induced gastric mucosal injuries in experimental portal hypertension |
Q33407319 | The diminished expression of proangiogenic growth factors and their receptors in gastric ulcers of cirrhotic patients |
Q37811452 | The management of portal hypertensive gastropathy and gastric antral vascular ectasia |
Q74428396 | Tumor necrosis factor alpha regulates nitric oxide synthase expression in portal hypertensive gastric mucosa of rats |
Q77620982 | Tumor necrosis factor-alpha regulates inducible nitric oxide synthase gene expression in the portal hypertensive gastric mucosa of the rat |
Q36811649 | Vasopressin plus oxygen vs vasopressin alone in cirrhotic patients with portal-hypertensive gastropathy: effects on gastric mucosal haemodynamics and oxygenation |
Q80291540 | Zinc L-carnosine protects against mucosal injury in portal hypertensive gastropathy through induction of heat shock protein 72 |
Search more.